Paul Goddard, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 11,500 shares at $32.71 ($376K) on 2007-08-15, disclosed to the SEC on 2007-08-16.
Open-market sale of $376k ONXX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.66 | 6,500 | $212K | 56.5% |
| 2 | $32.67 | 1,200 | $39K | 10.4% |
| 3 | $32.68 | 700 | $23K | 6.1% |
| 4 | $32.71 | 600 | $20K | 5.2% |
| 5 | $32.72 | 300 | $10K | 2.6% |
| 6 | $32.73 | 1,400 |
| $46K |
| 12.2% |
| 7 | $32.74 | 800 | $26K | 7.0% |
| Total | $32.68 avg | 11,500 | $376K | 100% |
| Filing → |
| ONXX | SELL | 2013-05-03 | $465K | — | Filing → |
| ONXX | SELL | 2013-04-11 | $190K | — | Filing → |
| ONXX | SELL | 2013-03-11 | $85K | — | Filing → |